Each year, four distinguished thought leaders in eye care sift through hundreds of posters, papers and presentations from the annual Association for Research in Vision and Ophthalmology (ARVO) meeting to bring you up to date on the latest clinical studies, therapeutic treatment options and surgical procedures.

Here, you’ll read about the topics that piqued their interest in Review’s 12th Annual ARVO Report:

Associate Clinical Editor Joseph P. Shovlin, O.D., editor of our “Cornea and Contact Lens Q+A” column, discusses the performance of current multifocal contact lenes, compares the findings from the 2009 and 2010 Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) studies and reviews the visual benefits of scleral contact lenses in keratoconus and corneal transplant patients.

Co-chief clinical editor Robert Cole III, O.D., analyzes the therapeutic efficacy of a new generic prostaglandin analogue, discusses the impact of IOP-lower agents on patients’ tear film and examines the relationship between choroidal thickness and ocular blood flow in glaucoma patients.

Cataract & Refractive Surgery
Clinical and Education Conference Director Paul M. Karpecki, O.D., coauthor of our “Research Review” column, explores cutting-edge applications of femtosecond laser technology, including deep anterior lamellar keratoplasty, astigmatism correction and corneal pocket creation for inlay implantation in LASIK patients.

Contributing editor Mark T. Dunbar, O.D., author of our “Retina Quiz” column, introduces the first results from the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) as well as reviews the clinical efficacy of several new treatments for diabetic macular edema, including topical dexamethasone eye drops.

To view any of the abstracts cited in the ARVO report that follows, go to www.arvo.org.